Aliaa Khalili – InmunoES

Rethinking immunotherapy sequencing in multiple myeloma: a conceptual adaptive immunotherapy sequencing model

15 de October de 2026 by Aliaa Khalili

BackgroundChimeric antigen receptor T-cell (CAR-T) therapy and bispecific antibodies (BsAbs) have transformed treatment for relapsed/refractory multiple myeloma (RRMM). Contemporary guidelines increasingly incorporate prior antigen-directed exposure, d…

Case Report: IVIG as a bridging strategy in high-risk antiphospholipid syndrome with infected cutaneous ulceration and thrombocytopenia

28 de July de 2026 by Aliaa Khalili

BackgroundSevere cutaneous ulceration in antiphospholipid syndrome (APS) with concurrent infection and thrombocytopenia presents a therapeutic dilemma: standard immunosuppression risks worsening infection, while anticoagulation risks hemorrhage. We pre…